William John Scheessele

HUMA

William John Scheessele serves as Chief Commercial Officer at Humacyte, Inc. (HUMA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$75.1K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$75.1K

Companies Traded

HUMA

Active Period

May 2022 – Apr 2025

3 total trades

Most Recent

Buy HUMA

Apr 14, 2025 · $10.0K

William John Scheessele's Insider Trading at Humacyte, Inc. (HUMA)

Buys

3 · $75.1K

Sells

0 · $0.00

Total Shares Bought

22,018

Total Shares Sold

HUMA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 14, 2025	Buy	6,493	$1.54	$10.0K	0
Dec 15, 2022	Buy	5,000	$3.09	$15.4K	15,525
May 25, 2022	Buy	10,525	$4.72	$49.7K	10,525

Related Insiders

Keith Anthony Jones

director

HUMABuy · Sep 15, 2026

Michael T. Constantino

director

HUMABuy · May 20, 2026

Shamik J Parikh

officer: Chief Medical Officer

HUMASell · May 20, 2026

Dale A. Sander

officer: CFO and Chief Corp. Dev. Off

HUMASell · May 20, 2026

Kathleen Sebelius

director

HUMABuy · May 20, 2026

Explore More Insider Trading Data

HUMA Insider Trading Activity

View all insider trades at Humacyte, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity